Delphi panel for consensus on the optimal management of dabrafenib plus trametinib-related pyrexia in patients with melanoma.
Saved in:
| Title: | Delphi panel for consensus on the optimal management of dabrafenib plus trametinib-related pyrexia in patients with melanoma. |
|---|---|
| Authors: | Frazer R; Consultant Medical Oncologist, Velindre University NHS Trust, Velindre Cancer Centre, Velindre Road, Cardiff, Wales CF14 2TL, UK., Gupta A; The Christie NHS Foundation Trust, Manchester, England., Herbert C; University Hospital Bristol, Bristol, England., Payne M; Oxford University Hospitals NHS Trust, Oxford, England., Diaz-Mendoza S; OPEN Health, Marlow, England., Vincent SA; OPEN Health, Marlow, England., Kovaleva E; Novartis Pharmaceuticals UK LTD, England. |
| Source: | Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2022 Oct 31; Vol. 14, pp. 17588359221127681. Date of Electronic Publication: 2022 Oct 31 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1758-8340 |
|---|---|
| DOI: | 10.1177/17588359221127681 |
